Overview

Subcuteous Methotrexate in Rheumatoid Arthritis

Status:
COMPLETED

Trial end date:
2016-06-01

Target enrollment:

Participant gender:

Summary

Methotrexate use is important for the treatment of Rheumatoid arthritis. Some patients can not tolerate oral methotrexate. So subcutaneous may help to overcome it.

Phase:

PHASE4

Details

Lead Sponsor:

Bangladesh Medical University